These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37620978)

  • 1. Clinical value of combined serum CA125, NSE and 24-hour urine VMA for the prediction of recurrence in children with neuroblastoma.
    Li J; Qi Z; Chen M; Wang J; Liu X
    Ital J Pediatr; 2023 Aug; 49(1):102. PubMed ID: 37620978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Values of serum CA125, NSE and 24-hour urine VMA in diagnosis and prediction of treatment of paediatric neuroblastoma.
    Li J; Liu X; Chen M; Wang J; Wang X
    Int J Clin Pract; 2021 Dec; 75(12):e14932. PubMed ID: 34606672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
    Zhang H; He X; Miao Q; Li L; Song J; Jiang X
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
    Simon T; Hero B; Hunneman DH; Berthold F
    Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma.
    Sun Q; Chen Y; Jin Q; Yuan X
    Eur J Pediatr; 2022 Dec; 181(12):4135-4147. PubMed ID: 36149505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
    Sadilkova K; Dugaw K; Benjamin D; Jack RM
    Clin Chim Acta; 2013 Sep; 424():253-7. PubMed ID: 23830883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening procedures for neuroblastoma: false-negative results.
    Johnsonbaugh RE; Cahill R
    Pediatrics; 1975 Aug; 56(2):267-70. PubMed ID: 1161374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neuron-specific enolase as a marker useful for monitoring the effectiveness of therapy in patients with neuroblastoma--as compared with urinary catecholamine metabolites.
    Hashimoto K; Gotoh Y; Tada K
    Tohoku J Exp Med; 1986 May; 149(1):25-30. PubMed ID: 3738914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma.
    Berthold F; Hunneman DH; Harms D; Käser H; Zieschang J
    Eur J Cancer; 1992; 28A(12):1950-4. PubMed ID: 1419287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
    Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
    Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
    Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
    Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
    Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
    Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors.
    Tsuchida Y; Honna T; Iwanaka T; Saeki M; Taguchi N; Kaneko T; Koide R; Tsunematsu Y; Shimizu K; Makino S
    J Pediatr Surg; 1987 May; 22(5):419-24. PubMed ID: 3585664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous measurement of VMA and HVA in 24-hour urine samples.
    Harr R
    Clin Lab Sci; 1991; 4(4):237-41. PubMed ID: 10149424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow-up of patients with neuroblastoma.
    Tuchman M; Robison LL; Maynard RC; Ramnaraine ML; Krivit W
    Clin Biochem; 1985 Jun; 18(3):176-9. PubMed ID: 4039636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer.
    Wang CF; Peng SJ; Liu RQ; Yu YJ; Ge QM; Liang RB; Li QY; Li B; Shao Y
    Dis Markers; 2020; 2020():8850873. PubMed ID: 33376560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preanalytical validation and reference values for a mass spectrometric assay of serum vanillylmandelic acid for screening of catecholamine secreting neuroendocrine tumors.
    Tohmola N; Itkonen O; Turpeinen U; Joenväärä S; Renkonen R; Hämäläinen E
    Clin Chim Acta; 2015 Jun; 446():206-12. PubMed ID: 25896957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
    Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
    In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
    Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
    Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
    Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
    Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.